A report sheds new light on Emergent executives’ own worries about deficiencies in the company’s quality control systems at its troubled Baltimore plant; no contaminated doses were ever released to the public.
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}